School | Page 227 of 257 | SpiritIndia.com

Health :: Pharmion enrolled first patient into Vidaza Patient Registry

Pharmion Corporation (Nasdaq: PHRM) announced today the enrollment of the first patient in AVIDA(TM), a registry for patients treated with Vidaza(R) (azacitidine for injectable suspension). Vidaza was approved in May 2004 for the treatment of all five French-American-British (FAB) subtypes of myelodysplastic syndromes (MDS): refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) if accompanied by neutropenia or thrombocytopenia or requiring transfusions; refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL). Myelodysplastic syndromes are a serious and life-threatening group of diseases in which the bone marrow does not function normally, resulting in the production of malformed or immature blood cells.

Education :: Physical education class more effective

A new approach to traditional high school gym class dramatically increases how often teens exercise outside of school.

Eyes :: Pakistani women 30 percent more likely to be blind than men

The odds of a woman in Pakistan being blind are 30 percent higher than for a Pakistani man according to a new survey published in the November 2006 issue of Investigative Ophthalmology & Visual Science (IOVS).

Pregnancy :: New study finds amniocentesis safer for pregnant women

Amniocentesis is the most commonly prescribed invasive test performed during pregnancies in the United States. Most women fear them while doctors recommend them based on guidelines from the American College of Obstetricians and Gynecologists. These guidelines stem from past research studies and recommendations by the CDC that were based only on maternal age.

Cancer :: Childhood cancer survivors treated with radiation face increased risk of tumors later in life

University of Minnesota cancer researchers found that children who received radiation treatment for cancer face an increased risk for brain and spinal column tumors later in life. The study will be published in the Nov. 1, 2006, issue of the Journal of the National Cancer Institute.

Education :: Poor readers have higher risk of suicidal thoughts and behavior

Teenagers with reading problems are at significantly higher risk for suicide and for dropping out of school than typical readers, according to a study by Wake Forest University Baptist Medical Center researchers.

Breast Cancer :: Unique estrogen receptor linked to metastatic breast cancer

Providence, RI ?V Breast cancer awareness month may have passed, but researchers remain focused on the disease with a new study showing that a unique estrogen receptor found in breast cancer tumors is a predictor of tumor size and metastases. The study, led by researchers at Rhode Island Hospital and Brown Medical School, is published in the November 1 issue of Clinical Cancer Research.

Kidney Stone :: Drug prescribed for migraines and seizures increases risk of kidney stones

Topiramate (Topamax), a drug commonly prescribed to treat seizures and migraine headaches, can increase the propensity of calcium phosphate kidney stones, researchers at UT Southwestern Medical Center have found.

Depression :: Carefully monitored treatment can help two-thirds of those who suffer from depression

More than two-thirds of people who suffer from major depression can become symptom-free if they are willing to work with their doctors and try various treatments to determine which work best for them, which may involve taking different antidepressants or adding cognitive therapy to the mix.

Restless Legs Syndrome :: Boehringer Ingelheim’s pramipexole effective in RLS patients

New data presented today show patients taking pramipexole (Mirapexin?/ Sifrol?) can experience significant improvements in a broad range of symptoms associated with Restless Legs Syndrome (RLS).1 In an additional study presented today, pramipexole was also shown to be well tolerated in RLS patients affected by concomitant diseases, which are commonly experienced in this patient group.2 The results of the studies were presented at the 10th International Congress of Parkinson?s Disease and Movement Disorders (MDS) in Kyoto, Japan.